These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 15514379

  • 21. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
    Busam KJ.
    Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
    [Abstract] [Full Text] [Related]

  • 22. NF-kappa B in the vascular progression of melanoma.
    Kashani-Sabet M, Shaikh L, Miller JR, Nosrati M, Ferreira CM, Debs RJ, Sagebiel RW.
    J Clin Oncol; 2004 Feb 15; 22(4):617-23. PubMed ID: 14966085
    [Abstract] [Full Text] [Related]

  • 23. Pregnancy and early-stage melanoma.
    Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ.
    Cancer; 2003 May 01; 97(9):2248-53. PubMed ID: 12712479
    [Abstract] [Full Text] [Related]

  • 24. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 25. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, Guerry D.
    J Clin Oncol; 2007 Mar 20; 25(9):1129-34. PubMed ID: 17369575
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Classification of localized melanoma by the exponential survival trees method.
    Huang X, Soong S, McCarthy WH, Urist MM, Balch CM.
    Cancer; 1997 Mar 15; 79(6):1122-8. PubMed ID: 9070489
    [Abstract] [Full Text] [Related]

  • 30. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.
    Ann Surg Oncol; 2008 Jan 15; 15(1):310-5. PubMed ID: 17987346
    [Abstract] [Full Text] [Related]

  • 31. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
    Leiter U, Buettner PG, Eigentler TK, Bröcker EB, Voit C, Gollnick H, Marsch W, Wollina U, Meier F, Garbe C.
    J Am Acad Dermatol; 2012 Jan 15; 66(1):37-45. PubMed ID: 21700361
    [Abstract] [Full Text] [Related]

  • 32. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.
    Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S, Shaw HM, Colman MH, Scolyer RA, Thompson JF.
    Ann Surg Oncol; 2008 Feb 28; 15(2):630-7. PubMed ID: 18080717
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
    Rangel J, Torabian S, Shaikh L, Nosrati M, Baehner FL, Haqq C, Leong SP, Miller JR, Sagebiel RW, Kashani-Sabet M.
    J Clin Oncol; 2006 Oct 01; 24(28):4565-9. PubMed ID: 17008696
    [Abstract] [Full Text] [Related]

  • 36. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 01; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 37. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL, Fine JA, Roush GC, Berwick M.
    Cancer; 1996 Aug 01; 78(3):427-32. PubMed ID: 8697387
    [Abstract] [Full Text] [Related]

  • 38. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S, Kamo R, Harada T, Ishii M.
    Osaka City Med J; 2009 Jun 05; 55(1):35-52. PubMed ID: 19725433
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.